135 related articles for article (PubMed ID: 11375795)
1. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
[TBL] [Abstract][Full Text] [Related]
2. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
[TBL] [Abstract][Full Text] [Related]
3. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
4. Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.
Fierabracci P; Pinchera A; Tonacchera M; Agretti P; De Marco G; Albertini S; Conforti G; Seregni E; Agresti R; Grasso L; Giani C
J Endocrinol Invest; 2004 Oct; 27(9):862-5. PubMed ID: 15648551
[TBL] [Abstract][Full Text] [Related]
5. [Autoantibody against Na+/I- symporter (NaIS)].
Zeki K
Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.
Endo T; Kaneshige M; Nakazato M; Kogai T; Saito T; Onaya T
Biochem Biophys Res Commun; 1996 Nov; 228(1):199-202. PubMed ID: 8912659
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
8. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
[TBL] [Abstract][Full Text] [Related]
9. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.
Agretti P; Dimida A; De Marco G; Ferrarini E; Rodrìguez Gonzàlez JC; Santini F; Vitti P; Pinchera A; Tonacchera M
J Endocrinol Invest; 2011 Mar; 34(3):170-4. PubMed ID: 20479570
[TBL] [Abstract][Full Text] [Related]
10. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
11. The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.
Muller I; Zhang L; Giani C; Dayan CM; Ludgate ME; Grennan-Jones F
J Endocrinol Invest; 2016 Mar; 39(3):323-31. PubMed ID: 26253711
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity involving the human sodium/iodide symporter: fact or fiction?
Heufelder AE; Joba W; Morgenthaler NG
Exp Clin Endocrinol Diabetes; 2001; 109(1):35-40. PubMed ID: 11573137
[TBL] [Abstract][Full Text] [Related]
14. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
[TBL] [Abstract][Full Text] [Related]
15. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter.
Tonacchera M; Pinchera A; Dimida A; Ferrarini E; Agretti P; Vitti P; Santini F; Crump K; Gibbs J
Thyroid; 2004 Dec; 14(12):1012-9. PubMed ID: 15650353
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease.
Endo T; Kogai T; Nakazato M; Saito T; Kaneshige M; Onaya T
Biochem Biophys Res Commun; 1996 Jul; 224(1):92-5. PubMed ID: 8694839
[TBL] [Abstract][Full Text] [Related]
17. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
18. Expression of the sodium iodide symporter in human kidney.
Spitzweg C; Dutton CM; Castro MR; Bergert ER; Goellner JR; Heufelder AE; Morris JC
Kidney Int; 2001 Mar; 59(3):1013-23. PubMed ID: 11231356
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a Chinese hamster ovary cell line, CHO-4J, stably expressing a number of Na+/I- symporters.
Kosugi S; Sasaki N; Hai N; Sugawa H; Aoki N; Shigemasa C; Mori T; Yoshida A
Biochem Biophys Res Commun; 1996 Oct; 227(1):94-101. PubMed ID: 8858109
[TBL] [Abstract][Full Text] [Related]
20. Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor.
Morgenthaler NG; Pampel I; Aust G; Seissler J; Scherbaum WA
Horm Metab Res; 1998 Mar; 30(3):162-8. PubMed ID: 9566861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
